Back to BARCLAYS PLC BARCLAYS PLC

PLRXPLRX
Showing 8 of 18 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in Pliant Therapeutics Inc

BARCLAYS PLC holds 426 shares of PLRX (Pliant Therapeutics Inc), worth $486 as of 2026-Q2. The position was increased (+1152.9% shares).

Current Value

$486

Current Shares

426

Total Value Change

-$4.7M

Total Shares Change

-421,073

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
426
+1152.9%
$4860.0%$1.14
12
2026-Q1
Decreased
34
-99.7%
$430.0%$1.25
0
2025-Q4
Decreased
10,584
-97.1%
$12,9120.0%$1.21
0
2025-Q3
Increased
369,556
+2767.9%
$546,9430.0%$1.49
39
2025-Q2
Decreased
12,886
-82.1%
$14,9480.0%$1.25
0
2025-Q1
Decreased
71,912
-29.4%
$97,0810.0%$1.47
0
2024-Q4
Decreased
101,823
-75.8%
$1.3M0.0%$12.79
0
2024-Q3
Increased
421,499
+22.9%
$4.7M0.0%$11.31
33

Other major holders of PLRX: BlackRock Finance, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used